News

Rocket Pharmaceuticals, Inc. a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces that the U.S. Food…
Read More...

Piramal Pharma Solutions announced that the company will be partnering with Epirium Bio on an exclusive manufacturing relationship for new orphan drugs targeting rare diseases with high…
Read More...

BeiGene, Ltd. and Singlomics Biopharmaceuticals Co., Ltd., announced that the companies have executed an exclusive license agreement for BeiGene to develop, manufacture and…
Read More...

Akers Biosciences, Inc. announced with its partner, Premas Biotech, positive proof of concept results from Animal Studies conducted during a 4 week test of its SARS-CoV-2 vaccine…
Read More...

Today, the first contract the European Commission has negotiated on behalf of the EU Member States with a pharmaceutical company entered into force following the formal signature…
Read More...

Ivy Brain Tumor Center at Barrow Neurological Institute announced today a new collaboration with Vivace Therapeutics. The Ivy Brain Tumor Center, which employs a bold, early-phase…
Read More...

HiFiBiO Therapeutics, a multinational biotherapeutics company focused on the development of novel antibodies for immunomodulation, announced the submission of an Investigational New…
Read More...

Novartis announced that, at primary analysis, the Phase III ASCEMBL study met its primary endpoint of statistically significant superiority in major molecular response (MMR) rate at 24…
Read More...

MedGenome, a leading genomic diagnostics, research and data company based in Foster City, CA and Bangalore, India, announced that it has formed a strategic discovery collaboration…
Read More...

Engitix Ltd, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, entered into a…
Read More...

ACADIA Pharmaceuticals Inc. announced the acquisition of CerSci Therapeutics, a clinical-stage biotechnology company with worldwide rights to a portfolio of novel compounds for…
Read More...

EpiVax, Inc. a Rhode Island-based company and recognized leader in the field of computational vaccinology, today announced it has out-licensed its COVID-19 vaccine candidate,…
Read More...

HitGen Inc. announced that the company has achieved a milestone in their strategic collaboration with Almirall to develop a novel class of drugs. The licensed compounds were identified…
Read More...

AbbVie and Harvard University announced a $30 million collaborative research alliance, launching a multi-pronged effort at Harvard Medical School (HMS) to study and develop novel…
Read More...

Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company announced that it has entered into a strategic collaboration with Vir Biotechnology, a clinical-stage immunology…
Read More...

Catalent, Inc. announced that Catalent Cell & Gene Therapy will provide drug substance manufacturing to AstraZeneca for the University of Oxford’s adenovirus vector-based COVID-19…
Read More...

PCI Pharma Services, a leading pharmaceutical and biopharmaceutical global supply chain solutions provider, and portfolio company of Partners Group, announced today the signing of a…
Read More...

Bristol Myers Squibb and Forbius, a privately held, clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic…
Read More...

Bio-Thera Solutions, Ltd. and BeiGene, Ltd. announced that the companies have executed a license, distribution, and supply agreement for China for Bio-Thera’s BAT1706, an…
Read More...

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company developing a novel immunotherapy platform to produce targeted polyclonal antibodies, announced the dosing of the…
Read More...